Diabetic foot osteomyelitis

Diabetes and Metabolism

Volumn 34, Issue 2, 2008, Pages 87-95

  Hartemann Heurtier, A ^a   Senneville, E ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Dron Hospital   (France)

Author keywords

Diabetic foot; Osteomyelitis; Review

Indexed keywords

8 QUINOLINOL INDIUM IN 111; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ETIDRONIC ACID TC 99M; FUSIDIC ACID; GENTAMICIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IMIDAZOLE; LEVOFLOXACIN; OFLOXACIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIGRANULOCYTE SCINTIGRAPHY; ARTERY DISEASE; BONE BIOPSY; BONE MARROW TOXICITY; BONE NECROSIS; BONE SCINTISCANNING; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTINUOUS INFUSION; CORYNEBACTERIUM; DIABETIC FOOT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ESCHERICHIA COLI; HEALING; HUMAN; KLEBSIELLA PNEUMONIAE; LABELLED AUTOLOGOUS LEUKOCYTE SCANNING; LABORATORY TEST; LIVER TOXICITY; MICROBIOLOGICAL EXAMINATION; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PHYSICAL EXAMINATION; PREVALENCE; PROTEUS; PSEUDOMONAS AERUGINOSA; RADIOGRAPHY; REMISSION; REVIEW; SCINTIGRAPHY; SCINTISCANNING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL TECHNIQUE;

ALGORITHMS; BONE AND BONES; DIABETIC FOOT; DIAGNOSIS, DIFFERENTIAL; FOOT; HUMANS; LEUKOCYTOSIS; OSTEOMYELITIS; PHYSICAL EXAMINATION;

EID: 42249105206     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.09.005     Document Type: Review

References (50)

1. Jeffcoate W.J., and Lipsky B.A. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 39 Suppl 2 (2004) S115-S122
2. O'Meara S., Nelson E.A., Golder S., Dalton J.E., Craig D., Iglesias C., et al. Systematic review of methods to diagnose infection in foot ulcers in diabetes. Diabet Med 23 (2006) 341-347
3. Nelson E.A., O'Meara S., Golder S., Dalton J., Craig D., Iglesias C., et al. Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 23 (2006) 348-359
4. Lipsky B.A., Berendt A.R., Deery H.G., Embil J.M., Joseph W.S., Karchmer A.W., et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39 (2004) 885-910
5. French clinical practice guidelines, Management of diabetic foot infections. Med Mal Infect 2007; 37: 26-50.
6. Grayson M.L., Gibbons G.W., Balogh K., Levin E., and Karchmer A.W. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 273 (1995) 721-723
7. Shone A., Burnside J., Chipchase S., Game F., and Jeffcoate W. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care 29 (2006) 945
8. Lavery L.A., Armstrong D.G., Peters E.J., and Lipsky B.A. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic?. Diabetes Care 30 (2007) 270-274
9. Ledermann H.P., Morrison W.B., and Schweitzer M.E. MR image analysis of pedal osteomyelitis: distribution, patterns of spread, and frequency of associated ulceration and septic arthritis. Radiology 223 (2002) 747-755
10. Lavery L.A., Armstrong D.G., Wunderlich R.P., Mohler M.J., Wendel C.S., and Lipsky B.A. Risk factors for foot infections in individuals with diabetes. Diabetes Care 29 (2006) 1288-1293
11. Ha Van G., Siney H., Hartmann-Heurtier A., Jacqueminet S., Greau F., and Grimaldi A. Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance. Diabetes Care 26 (2003) 2848-2852
12. Walker S.C., Helm P.A., and Pullium G. Total contact casting and chronic diabetic neuropathic foot ulcerations: healing rates by wound location. Arch Phys Med Rehabil 68 (1987) 217-221
13. Lipsky B.A. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 25 (1997) 1318-1326
14. Senneville E., Melliez H., Beltrand E., Legout L., Valette M., Cazaubiel M., et al. Culture of percutaneous bone biopsy specimens for diagnosis foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 42 (2006) 57-62
15. Wheat L.J., Allen S.D., Henry M., Kernek C.B., Siders J.A., Kuebler T., et al. Diabetic foot infections: bacteriologic analysis. Arch Phys Med Rehabil 146 (1986) 1935-1940
16. Armstrong D.G., Lanthier J., Lelievre P., and Edelson G.W. Methicillin-resistant coagulase-negative staphylococcal and its relationship to broad-spectrum oral antibiosis in a predominantly diabetic population. J Foot Ankle Surg 34 (1995) 353-356
17. Besman A.N., Geiger P.J., and Canawati H. Prevalence of corynebacteria in diabetic foot infections. Diabetes Care 15 (1992) 1531-1533
18. Lavery L.A., Sariaya M., Ashry H., and Harkless L.B. Microbiology of osteomyelitis in diabetic foot infections. J Foot Ankle Surg 34 (1995) 61-64
19. Newman L.G., Waller J., Palestro C.J., Schwartz M., Klein M.J., Hermann G., et al. Unsuspected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with indium 111 oxyquinoline. JAMA 266 (1991) 1246-1251
20. Rajbhandari S.M., Sutton M., Davies C., Tesfaye S., and Ward J.D. 'Sausage toe': a reliable sign of underlying osteomyelitis. Diabet Med 17 (2000) 74-77
21. Armstrong D.G., Lavery L.A., Sariaya M., and Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 35 (1996) 280-283
22. Sutton P., Harley J., Jacobson A., and Lipsky B.A. Diagnosing osteomyelitis with percutaneous bone biopsy in patients with diabetes and foot infection. In: Alexandria V.A. (Ed). Infectious Diseases Society of America (2000) [abstract 30]
23. Kessler L., Piemont, Ortega F., Lesens O., Boeri C., Averous C., et al. Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis. Diabet Med 23 (2006) 99-102
24. White L.M., Schweitzer M.E., Deely D.M., and Gannon F. Study of osteomyelitis: utility of combined histologic and microbiologic evaluation of percutaneous biopsy samples. Radiology 197 (1995) 840-842
25. Ertugrul M.B., Baktiroglu S., Salman S., Unal S., Aksoy M., Berberoglu K., et al. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diabet Med 23 (2006) 649-653
26. Witso E., Persen L., Loseth K., and Bergh K. Adsorption and release of antibiotics from morselized cancellous bone: in vitro studies of 8 antibiotics. Acta Orthop Scand 70 (1999) 298-304
27. Levine S.E., Neagle C.E., Esterhai J.L., Wright D.G., and Dalinka M.K. Magnetic resonance imaging for the diagnosis of osteomyelitis in the diabetic patient with a foot ulcer. Foot Ankle Int 15 (1994) 151-156
28. Shults D.W., Hunter G.C., McIntyre K.E., Parent F.N., Piotrowski J.J., and Bernhard V.M. Value of radiographs and bone scans in determining the need for therapy in diabetic patients with foot ulcers. Am J Surg 158 (1989) 525-529
29. Enderle M.D., Coerper S., Schweizer H.P., Kopp A.E., Thelen M.H., Meisner C., et al. Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high-resolution ultrasound. Diabetes Care 22 (1999) 294-299
30. Poirier J.Y., Garin E., Derrien C., Devillers A., Moisan A., Bourguet P., et al. Diagnosis of osteomyelitis in the diabetic foot with a 99mTc-HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy. Diabetes Metab 28 (2002) 485-490
31. Palestro C.J., Caprioli R., Love C., Richardson H.L., Kipper S.L., Weiland F.L., et al. Rapid diagnosis of pedal osteomyelitis in diabetics with a technetium-99m-labeled monoclonal antigranulocyte antibody. J Foot Ankle Surg 42 (2003) 2-8
32. Rubello D., Casara D., Maran A., Avogaro A., Tiengo A., and Muzzio P.C. Role of anti-granulocyte Fab' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results. Nucl Med Commun 25 (2004) 39-47
33. Craig J.G., Amin M.B., Wu K., Eyler W.R., van Holsbeeck M.T., Bouffard J.A., et al. Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology 203 (1997) 849-855
34. Marcus C.D., Ladam-Marcus V.J., Leone J., Malgrange D., Bonnet-Gausserand F.M., and Menanteau B.P. MR imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics. Radiographics 16 (1996) 1337-1348
35. Ledermann H.P., Schweitzer M.E., and Morrison W.B. Nonenhancing tissue on MR imaging of pedal infection: characterization of necrotic tissue and associated limitations for diagnosis of osteomyelitis and abscess. Am J Roentgenol 178 (2002) 215-222
36. Lipman B.T., Collier B.D., Carrera G.F., Timins M.E., Erickson S.J., Johnson J.E., et al. Detection of osteomyelitis in the neuropathic foot: nuclear medicine. MRI and conventional radiography. Clin Nucl Med 23 (1998) 77-82
37. Ahmadi M.E., Morrison W.B., Carrino J.A., Schweitzer M.E., Raikin S.M., and Ledermann H.P. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology 238 (2006) 622-631
38. Murdoch D.P., Armstrong D.G., Dacus J.B., Laughlin T.J., Morgan C.B., and Lavery L.A. J The natural history of great toe amputations. Foot Ankle Surg 36 (1997) 204-208
39. Van Baal J.G. Surgical treatment of the infected diabetic foot. Clin Infect Dis 39 Suppl 2 (2004) S123-S128
40. Nehler M.R., Whitehill T.A., Bowers S.P., Jones D.N., Hiatt W.R., Rutherford R.B., et al. Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status. J Vasc Surg 30 (1999) 509-517
41. Tan J.S., Friedman N.M., Hazelton-Miller C., Flanagan J.P., and File Jr. T.M. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?. Clin Infect Dis 23 (1996) 286-291
42. Venkatesan P., Lawn S., Macfarlane R.M., Fletcher E.M., Finch R.G., and Jeffcoate W.J. Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 14 (1997) 487-490
43. Pittet D., Wyssa B., Herter-Clavel C., Kursteiner K., Vaucher J., and Lew D.P. Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med 159 (1999) 851-856
44. Senneville E., Yazdanpanah Y., Cazaubiel M., Cordonnier M., Valette M., Beltrand E., et al. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 48 (2001) 927-930
45. Diamantopoulos E.J., Haritos D., Yfandi G., Grigoriadou M., Margariti G., Paniara O., et al. Management of severe diabetic foot infections. Exp Clin Endocrinol Diabetes 106 (1998) 346-352
46. Yadlapalli N.G., Vaishnav A., and Sheehan P. Conservative management of diabetic foot ulcers complicated by osteomyelitis. Wounds 14 (2002) 31-35
47. Embil J.M., Rose G., Trepman E., Cheang M., Duerksen R., Simonsen J.N., and Nicolle L.E. Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int 27 (2006) 771-779
48. Zuluaga A.F., Galvis W., Jaimes F., and Vespa O. Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study. BMC Infect Dis 2 (2002) 8
49. Khatri G., Wagner D.K., and Sohnle P.G. Effect of bone biopsy in guiding antimicrobial therapy for osteomyelitis complicating open wounds. Am J Med Sci 321 (2001) 367-371
50. Zuluaga A.F., Galvis W., Saldarriaga J.G., Agudelo M., Salazar B.E., and Vesga O. Etiologic diagnosis of chronic osteomyelitis: a prospective study. Arch Intern Med 166 (2006) 95-100